Mangoceuticals (MGRX) Debt Ratio (2022)
Mangoceuticals (MGRX) reported Debt Ratio of 0.08 for Q4 2022.
Mangoceuticals (MGRX) Debt Ratio (2022) Analysis & Trends
Mangoceuticals (MGRX) has 1 years of Debt Ratio data on file, last reported at 0.08 in Q4 2022.
- For the quarter ending Q4 2022, Debt Ratio changed N/A year-over-year to 0.08; the trailing twelve-month figure through Dec 2022 stood at 0.08 (changed N/A YoY), and the FY2022 full-year result was 0.08, changed N/A from the prior year.
- Debt Ratio held at 0.08 in Q4 2022.
- In the past five years, Debt Ratio ranged from a high of 0.08 in Q4 2022 to a low of 0.08 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 32.18 Bn | 24.87 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 14.67 Bn | 13.77 Bn | 482.22 Mn | 0.40 |
| 3 | Healthequity | 8.42 Bn | 8.15 Bn | 256.31 Mn | 0.29 |
| 4 | Hinge Health | 5.96 Bn | 5.65 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn | - |
| 6 | MiniMed | 4.52 Bn | 4.22 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.46 Bn | 4.40 Bn | 216.84 Mn | 0.25 |
| 8 | Doximity | 3.96 Bn | 3.21 Bn | 125.97 Mn | - |
| 9 | Privia Health | 3.13 Bn | 2.71 Bn | - | - |
| 10 | Mangoceuticals | 9.25 Mn | 9.05 Mn | 29,001.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 0.08 |